squalamine lactate
Sponsors
Jonsson Comprehensive Cancer Center, Genaera Corporation, OHSU Knight Cancer Institute, Ohr Pharmaceutical Inc.
Conditions
Neovascular Age Related Macular DegenerationOvarian CancerProstate CancerWet Age-Related Macular Degeneration
Phase 2
Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
NCT00021385
Start: 2001-05-31Updated: 2013-12-18
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
WithdrawnNCT00244920
Start: 2002-01-31End: 2007-06-30Updated: 2012-05-28
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
CompletedNCT01678963
Start: 2012-11-30End: 2015-03-31Updated: 2015-06-12